Albendazole 200 mg Oral Tablet
RxNorm 199672
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 199672 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: albendazole 200 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Albendazole 200 mg Oral Tablet
(Atom ID: 12324170)
PSNPrescribable
Prescribable Name (PSN):
Albendazole 200 mg Oral Tablet
(Atom ID: 6365297)
PTPrescribable
Designated preferred name (PT):
Albendazole 200 mg oral tablet
(Atom ID: 9248511)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely albendazole 200 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10308889)
Patient Education
Albendazole
Albendazole is used to treat neurocysticercosis (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). Albendazole is also used along with surgery to treat cystic hydatid disease (infection caused by the dog tapeworm in the liver, lung, and lining of the abdomen that may damage these organs). Albendazole is in a class of medications called antihelmintics. It works by killing the worms.
[Learn More]
* Please review the disclaimer below.